World

Moldova formally protests alleged Russian election meddling

Nov 13, 2024

Chisinau [Moldova], November 13: Moldova has handed a note of protest to the Russian ambassador to Chisinau over alleged interference in its recent elections.
The foreign ministry in Chisinau said in a statement on Tuesday that it turned over the "note of firm protest" in relation to the "illegal and deliberate interference" to envoy Oleg Ozerov during a meeting at its offices. Moldova has accused Russia of seeking to influence its recent presidential election and referendum on joining the European Union.
Russia sought to affect results and delegitimise the democratic process, the ministry complained.
Chisinau accused Russia of organising ineligible voting, bribery, and security threats in a bid to influence the votes.
Moscow denies trying to sway the election, which was narrowly won by pro-Western President Maia Sandu, aided by votes from Moldovans outside the country.
Moldova also narrowly voted in favour of inserting a clause in its constitution to define EU membership as a goal. Russia has maintained that the votes were unfair and does not view Sandu as the legitimate president. (Agencies)
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025